Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.

Article  PubMed  Google Scholar 

Takayama KI, Kosaka T, Suzuki T, Hongo H, Oya M, et al. Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer. Nat Commun. 2021;12:3766.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149:779–89.

Rawla P. Epidemiology of prostate Cancer. World J Oncol. 2019;10:63–89.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Walz S, Maas M, Stenzl A, Todenhöfer T. Bone health issues in patients with prostate Cancer: an evidence-based review. World J Mens Health. 2020;38:151–63.

Article  PubMed  Google Scholar 

Carlin BI, Andriole GL. The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma. Cancer. 2000;88:2989–94.

Article  PubMed  CAS  Google Scholar 

Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, et al. Prostate-specific antigen-based screening for prostate Cancer: evidence report and systematic review for the US preventive services task force. Jama. 2018;319:1914–31.

Article  PubMed  Google Scholar 

Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch H, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31:578–83.

Article  PubMed  CAS  Google Scholar 

Zhong Y, Valderrama A, Yao J, Donga P, Bilir P, et al. Economic evaluation of treating skeletal-related events among prostate Cancer patients. Value Health. 2018;21:304–9.

Article  PubMed  Google Scholar 

Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, et al. Management of Patients with advanced prostate Cancer: report of the advanced prostate Cancer consensus conference 2019. Eur Urol. 2020;77:508–47.

Article  PubMed  CAS  Google Scholar 

Nieder C, Stanisavljevic L. Independent validation of a risk stratification model predicting survival in patients with metastatic hormone-sensitive prostate Cancer. Anticancer Res. 2022;42:3675–9.

Article  PubMed  Google Scholar 

Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:e173–80.

Article  PubMed  PubMed Central  Google Scholar 

Kong J, Zheng J, Cai J, Wu S, Diao X, et al. A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study. Cancer Commun. 2019;39:80.

Article  Google Scholar 

He C, Zhang Y, Cai Z, Lin X. Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery. BMC Cancer. 2019;19:178.

Article  PubMed  PubMed Central  Google Scholar 

Shi R, Zhang T, Sun H, Hu F. Establishment of clinical prediction model based on the study of risk factors of stroke in patients with type 2 diabetes mellitus. Front Endocrinol. 2020;11:559.

Article  Google Scholar 

van Steenbeek CD, van Maaren MC, Siesling S, Witteveen A, Verbeek X, et al. Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands. BMC Med Res Methodol. 2019;19:117.

Article  PubMed  PubMed Central  Google Scholar 

Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak. 2006;26:565–74.

Article  Google Scholar 

Kim SH, Cho SH, Kim WH, Kim HJ, Park JM, et al. Predictors of Extraprostatic extension in patients with prostate Cancer. J Clin Med. 2023;12:5321.

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33.

Article  PubMed  Google Scholar 

Weiner AB, Matulewicz RS, Eggener SE, Schaeffer EM. Increasing incidence of metastatic prostate cancer in the United States (2004–2013). Prostate Cancer Prostatic Dis. 2016;19:395–7.

Article  PubMed  CAS  Google Scholar 

Kelly SP, Anderson WF, Rosenberg PS, Cook MB. Past, current, and future incidence rates and burden of metastatic prostate Cancer in the United States. Eur Urol Focus. 2018;4:121–7.

Article  PubMed  Google Scholar 

Liu D, Kuai Y, Zhu R, Zhou C, Tao Y, et al. Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China. Sci Rep. 2020;10:9104.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sun D, Lin A, Sun Z, Yang S, Sun Y, et al. Nomograms predict survival benefits of radical prostatectomy and chemotherapy for prostate cancer with bone metastases: a SEER-based study. Front Oncol. 2022;12:1020898.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Z, Zhanghuang C, Wang J, Mi T, Liu J, et al. A web-based prediction model for Cancer-specific survival of elderly patients undergoing surgery with prostate Cancer: a population-based study. Front Public Health. 2022;10:935521.

Article  PubMed  PubMed Central  Google Scholar 

Sauter G, Steurer S, Clauditz TS, Krech T, Wittmer C, et al. Clinical utility of quantitative Gleason grading in prostate biopsies and prostatectomy specimens. Eur Urol. 2016;69:592–8.

Article  PubMed  Google Scholar 

Mahal BA, Yang DD, Wang NQ, Alshalalfa M, Davicioni E, et al. Clinical and genomic characterization of low-prostate-specific antigen, high-grade prostate Cancer. Eur Urol. 2018;74:146–54.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Qin XJ, Ma CG, Ye DW, Yao XD, Zhang SL, et al. Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer. Urol Oncol. 2012;30:145–9.

Article  PubMed  Google Scholar 

Mathieu R, Korn SM, Bensalah K, Kramer G, Shariat SF. Cytoreductive radical prostatectomy in metastatic prostate cancer: does it really make sense? World J Urol. 2017;35:567–77.

Article  PubMed  Google Scholar 

Petrylak DP, Tangen CM, Hussain MH, Lara PN Jr, Jones JA, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004;351:1513–20.

Article  PubMed  CAS  Google Scholar 

Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate Cancer. Part II-2020 update: treatment of relapsing and metastatic prostate Cancer. Eur Urol. 2021;79:263–82.

Article  PubMed  CAS  Google Scholar 

Parker CC, James ND, Brawley CD, Clarke NW, Hoyle AP, et al. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Lancet. 2018;392:2353–66.

Article  PubMed  PubMed Central  Google Scholar 

Cuzick J, Thorat MA, Andriole G, Brawley OW, Brown PH, et al. Prevention and early detection of prostate cancer. Lancet Oncol. 2014;15:e484–92.

Article  PubMed  PubMed Central  Google Scholar 

Mahal BA, Berman RA, Taplin ME, Huang FW. Prostate Cancer-specific mortality across Gleason scores in black vs nonblack men. JAMA. 2018;320:2479–81.

Article  PubMed  Google Scholar 

Huang TB, Zhou GC, Dong CP, Wang LP, Luan Y, et al. Marital status independently predicts prostate cancer survival in men who underwent radical prostatectomy: an analysis of 95,846 individuals. Oncol Lett. 2018;15:4737–44.

PubMed  PubMed Central  Google Scholar 

Jiang WD, Yuan PC. Development and validation of prognostic nomograms for patients with metastatic prostate cancer. Int Urol Nephrol. 2019;51:1743–53.

Article  PubMed  CAS  Google Scholar 

Abdollah F, Sun M, Thuret R, Abdo A, Morgan M, et al. The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: a population-based study. Cancer Causes Control. 2011;22:1085–95.

Article  PubMed  Google Scholar 

Guo X, Zhang C, Guo Q, Xu Y, Feng G, et al. The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer. Cancer Manag Res. 2018;10:1639–46.

Article  PubMed  PubMed Central  Google Scholar 

Vaarala MH, Hirvikoski P, Kauppila S, Paavonen TK. Identification of androgen-regulated genes in human prostate. Mol Med Rep. 2012;6:466–72.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhao F, Wang J, Chen M, Chen D, Ye S, et al. Sites of synchronous distant metastases and prognosis in prostate cancer patients with bone metastases at initial diagnosis: a population-based study of 16,643 patients. Clin Transl Med. 2019;8:30.

Article  PubMed  PubMed Central  Google Scholar 

Deng Y, Bi R, Zhu Z, Li S, Xu B, et al. A s